Intellia Therapeutics, Inc. (NTLA)
15.45
+1.67
(+12.12%)
USD |
NASDAQ |
Mar 02, 16:00
15.18
-0.27
(-1.75%)
After-Hours: 20:00
Intellia Therapeutics Research and Development Expense (Annual) : 379.09M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Beam Therapeutics, Inc. | 409.62M |
| Personalis, Inc. | 50.26M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Pacific Biosciences of California, Inc. | 95.21M |
| Twist Bioscience Corp. | 80.28M |